Mersana Therapeutics
MRSN | NASDAQ
$29.08
$0.00 (0.00%)
At close: Jan 5, 2026, 3:55 PM ET
+0.00%
(1D)Rating
Key Statistics
Market Data
Market Cap $145.36M
1D Range
28.78 29.08
52W Range
5.21 30.39
Valuation (TTM)
PE -2.06
PB -2.44
EV/EBITDA -1.38
Valuation (NTM)
Forward PE N/A
Forward PEG -0.13
Price Target $10.00
Cash Flow
FCF Yield -51.2%
SBC Adj. FCF Yield -57.5%
SBC Impact -12.5%
Margins
Gross Margin 98.0%
Operating Margin -203.1%
FCF Margin -224.1%
Growth (CAGR)
Revenue 3Y | 5Y 40.7% |
107.6%
Dil EPS 3Y | 5Y 61.8% |
33.1%
FCF 3Y | 5Y 48.4% |
2.8%
Returns
ROA -50.8%
ROE 56.5%
ROIC -129.2%
Financial Health
Net Cash
$56.39M
Current Ratio 1.39
Interest Coverage -26.27
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to pioneering novel antibody-drug conjugates (ADCs) for cancer patients with pressing unmet medical needs. Their flag...
Sector Healthcare
Industry Biotechnology
Employees 102
IPO Date Jun 28, 2017
Website www.dayonebio.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
3
Consensus
Hold
Price Target
$10.00
Downside
-65.61%
Buy (0)
Hold (3)
Sell (0)
Add to Watchlist
Select watchlists to add or remove MRSN